Belite Bio (BLTE) Receivables - Other (2022 - 2025)
Belite Bio (BLTE) recorded quarterly Receivables - Other of $700000.0 in Q4 2025, up 11766.67% quarter-over-quarter from -$6000.0 in Q3 2025, and up 21.74% on a YoY basis from $575000.0 in Q4 2024.
Belite Bio (BLTE) Receivables - Other (2022 - 2025) Analysis & Trends
Belite Bio's Receivables - Other history runs 4 years deep, the most recent figure standing at $700000.0 for Q4 2025.
- In Q4 2025, Receivables - Other rose 21.74% year-over-year to $700000.0; the TTM figure through Dec 2025 stood at $700000.0 (up 21.74% YoY), while the FY2025 annual figure was $700000.0, up 21.74% from the prior year.
- Receivables - Other was $700000.0 for Q4 2025 at Belite Bio, up from -$6000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $818000.0 in Q4 2023 to a low of -$6000.0 in Q3 2025.
- Historically, Receivables - Other has averaged $357500.0 across 4 years, with a median of $315500.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Receivables - Other surged 40800.0% in 2023, then sank 110.71% in 2025.
- A 4-year view of Receivables - Other shows it stood at $2000.0 in 2022, then soared by 40800.0% to $818000.0 in 2023, then declined by 29.71% to $575000.0 in 2024, then advanced by 21.74% to $700000.0 in 2025.
- The last three Receivables - Other figures came in at $700000.0 (Q4 2025), -$6000.0 (Q3 2025), and $575000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 700,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Dec 31, 2024 | 575,000.00 |
| Dec 31, 2024 | 575,000.00 |
| Sep 30, 2024 | 56,000.00 |
| Sep 30, 2024 | 56,000.00 |
| Dec 31, 2023 | 818,000.00 |
| Dec 31, 2023 | 818,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Dec 31, 2022 | 2,000.00 |